PHI Group Subsidiary Completes Merger With Humex Medical for Stem Cell Research and Therapy
June 29 2011 - 9:15AM
Marketwired
PHI Group, Inc. (OTCQB: PHIE) (PINKSHEETS: PHIE) (FRANKFURT: PR7),
a company focused on M&A consulting services, real estate
development, natural resources, energy and special situations,
announced today that its subsidiary Provimex, Inc. has completed
its merger with Humex Medical Group, Inc., a California
corporation, to engage in stem cell research and therapies in
Southeast Asia.
According to the corporate combination agreement between Humex
and Provimex, Humex exchanged all its issued and outstanding shares
for 58,333,333 shares of newly issued common stock of Provimex,
Inc., equivalent to 70% ownership in Provimex. PHI Group and its
shareholders retain 30% in the combined company.
Both Humex and Provimex are nearing the completion of their
financial audits and will file a registration statement with the
Securities and Exchange Commission to become a new fully reporting
publicly traded company. The combined company has decided to change
its corporate name to HEET Biocell Group instead of the previously
proposed name.
Eric Jeong, President of Humex Medical Group, said, "We are
pleased to have completed the business combination between Provimex
and Humex Medical and anticipate launching our stem cell research,
banking and treatment activities in Southeast Asia soon."
Henry Fahman, Chairman of PHI Group, said, "Along with Provimex,
we also are in the process of combining our other subsidiaries,
including Touchlink Communications, E-check Recovery and Irvine
College of Medical Sciences, with businesses that have potential
for high growth to create additional value for our
shareholders."
About Humex - HEET Biocell Group An
affiliate of RNL Bio (http://www.rnl.co.kr/eng/main.asp), a leading
Korean biotech company focused on stem cell research and therapies,
Humex Medical Group has been engaged in cosmetic surgeries,
anti-aging and regenerative treatments. HEET Biocell Group will
focus on stem cell research, stem cell therapeutics, stem cell base
cosmetics and adult stem cell banking services.
About PHI Group PHIGroup engages in
M&A consulting services, real estate, natural resources,
energy, and special situations. PHIGroup takes companies public in
the U.S. and Europe and provides access to international capital
sources through its subsidiaries PHI Capital Holdings and PHI
Vietnam Holdings (www.phiholdings.com), develops real estate
projects in Vietnam through PHILand Ranch (www.philandranch.com);
(FRANKFURT: 1P8), and engages in natural resources and energy
through PHI Gold Corporation (PINKSHEETS: PHIG), Tricon Gold Corp,
PHI Energy Corp (www.phienergycorp.com) and PHI Oil and Gas Ltd.
Main corporate website: www.phiglobal.com
Safe Harbor: This news release contains forward-looking
statements that are subject to certain risks and uncertainties that
may cause actual results to differ materially from those projected
on the basis of such forward-looking statements. Such
forward-looking statements are made based upon management's
beliefs, as well as assumptions made by, and information currently
available to, management pursuant to the "safe-harbor" provisions
of the Private Securities Litigation Reform Act of 1995.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Contact: Henry Fahman 714-843-5455 Email Contact
PHI (CE) (USOTC:PHIG)
Historical Stock Chart
From Dec 2024 to Jan 2025
PHI (CE) (USOTC:PHIG)
Historical Stock Chart
From Jan 2024 to Jan 2025